Guidelines for living donor kidney transplantation
Por:
Frutos, M, Crespo, M, Valentin, M, Alonso-Melgar, A, Alonso, J, Fernandez, C, Garcia-Erauzkin, G, Gonzalez, E, Gonzalez-Rinne, A, Guirado, L, Gutierrez-Dalmau, A, Huguet, J, del Moral, J, Musquera, M, Paredes, D, Redondo, D, Revuelta, I, Hofstadt, C, Alcaraz, A, Alonso-Hernandez, A, Alonso, M, BERNABEU JUAN, P, Bernal, G, Breda, A, Cabello, M, Caro-Oleas, J, Cid, J, Diekmann, F, Espinosa, L, Facundo, C, Garcia, M, Gil-Vernet, S, Lozano, M, Mahillo, B, Martinez, M, Miranda, B, Oppenheimer, F, Palou, E, Perez-Saez, M, Peri, L, Rodriguez, O, Santiago, C, Tabernero, G, Hernandez, D, Dominguez-Gil, B and Pascual, J
Publicada:
1 abr 2022
Ahead of Print:
1 abr 2022
Resumen:
This guide for living donor renal transplantation (LDRT) has been prepared with the sponsorship of the Spanish Society of Nephrology (SEN), the Spanish Transplant Society (SET), and the Spanish National Transplant Organization (ONT). It updates evidence to offer the best chronic renal failure treatment when a potential living donor is available. The core aim of this guide is to supply clinicians who evaluate living donors and transplant recipients with the best decision-making tools, to optimise their outcomes.
Moreover, the role of living donors in the current RT context should recover the level of importance it had until recently. To this end the new forms of incompatible HLA and/or ABO donation, as well as the paired donation which is possible in several hospitals with experience in LDRT, offer additional ways to treat renal patients with an incompatible donor. Good results in terms of patient and graft survival have expanded the range of circumstances under which living renal donors are accepted. Older donors are now accepted, as are others with factors that affect the decision, such as a borderline clinical history or alterations, which when evaluated may lead to an additional number of transplantations.
This guide does not forget that LDRT may lead to risk for the donor. Pre-donation evaluation has to centre on the problems which may arise over the short or long-term, and these have to be described to the potential donor so that they are able to take them into account. Experience over recent years has led to progress in risk analysis, to protect donors' health. This aspect always has to be taken into account by LDRT programmes when evaluating potential donors.
Finally, this guide has been designed to aid decision-making, with recommendations and suggestions when uncertainties arise in pre-donation studies. Its overarching aim is to ensure that informed consent is based on high quality studies and information supplied to donors and recipients, offering the strongest possible guarantees. (C) 2021 Published by Elsevier Espana, S.L.U. on behalf of Sociedad Espanola de Nefrologia.
Filiaciones:
Frutos, M:
Hosp Reg Univ Malaga, Serv Nefrol, Malaga, Spain
Crespo, M:
Hosp Mar, Serv Nefrol, Barcelona, Spain
Valentin, M:
Org Nacl Trasplantes, Madrid, Spain
Alonso-Melgar, A:
Hosp La Paz, Serv Nefrol Pediat, Madrid, Spain
Alonso, J:
Hosp Reg Univ Malaga, Serv Nefrol, Malaga, Spain
Fernandez, C:
Hosp Univ A Coruna, Serv Nefrol, La Coruna, Spain
Garcia-Erauzkin, G:
Hosp Univ Cruces, Serv Nefrol, Bilbao, Spain
Gonzalez, E:
Hosp Univ 12 Octubre, Serv Nefrol, Madrid, Spain
Gonzalez-Rinne, A:
Hosp Univ Canarias, Serv Nefrol, Santa Cruz De Tenerife, Spain
Guirado, L:
Fundacio Puigvert, Serv Nefrol, Barcelona, Spain
Gutierrez-Dalmau, A:
Hosp Univ Miguel Seruet, Serv Nefrol, Zaragoza, Spain
Huguet, J:
Fundacio Puigvert, Equipo Quirurg TR, Barcelona, Spain
del Moral, J:
Magistrado Tribunal Super Justicia Cantabria, Cantabria, Spain
Musquera, M:
Hosp Clin Univ, Serv Urol, Barcelona, Spain
Paredes, D:
Hosp Clin Univ, Secc Donac & Coordinac Trasplantes, Barcelona, Spain
Redondo, D:
Hosp Mar, Serv Nefrol, Barcelona, Spain
Revuelta, I:
Hosp Clin Univ, Serv Nefrol & TR, Barcelona, Spain
:
Hosp Gen Univ Alicante, Unidad Psicol Hosp, Alicante, Spain
Alcaraz, A:
Hosp Clin Univ, Serv Urol, Barcelona, Spain
Alonso-Hernandez, A:
Hosp Univ A Coruna, Serv Nefrol, La Coruna, Spain
Alonso, M:
Coordinac Autonom Trasplantes, Seville, Spain
:
Hosp Gen Univ Alicante, Unidad Psicol Hosp, Alicante, Spain
Bernal, G:
Hosp Univ Virgen Rocio, Serv Nefrol, Seville, Spain
Breda, A:
Fundacio Puigvert, Equipo Quirurg TR, Barcelona, Spain
Cabello, M:
Hosp Reg Univ Malaga, Serv Nefrol, Malaga, Spain
Caro-Oleas, J:
Hosp Clin & Univ, Serv Inmunol, Barcelona, Spain
Cid, J:
Hosp Clin Univ, Serv Hemoterapia & Hemostasia, Unidad Aferesis & Terapia Celular, Barcelona, Spain
Diekmann, F:
Hosp Clin Univ, Serv Nefrol & TR, Barcelona, Spain
Espinosa, L:
Hosp La Paz, Serv Nefrol Pediat, Madrid, Spain
Facundo, C:
Fundacio Puigvert, Serv Nefrol, Barcelona, Spain
Garcia, M:
Org Nacl Trasplantes, Madrid, Spain
Gil-Vernet, S:
Hosp Univ Bellvitge, Serv Nefrol, Barcelona, Spain
Lozano, M:
Hosp Clin Univ, Serv Hemoterapia & Hemostasia, Unidad Aferesis & Terapia Celular, Barcelona, Spain
Mahillo, B:
Org Nacl Trasplantes, Madrid, Spain
Martinez, M:
Hosp Univ La Paz, Serv Urol Pediat, Madrid, Spain
Miranda, B:
Fdn Renal Inigo Alvarez Toledo, Madrid, Spain
Oppenheimer, F:
Hosp Clin Univ, Serv Nefrol & TR, Barcelona, Spain
Palou, E:
Hosp Clin & Univ, Serv Inmunol, Barcelona, Spain
Perez-Saez, M:
Hosp Mar, Serv Nefrol, Barcelona, Spain
Peri, L:
Hosp Clin Univ, Serv Urol, Barcelona, Spain
Rodriguez, O:
Fundacio Puigvert, Equipo Quirurg TR, Barcelona, Spain
:
Hosp Gen Alicante, Serv Nefrol, Alicante, Spain
Tabernero, G:
Hosp Univ Salamanca, Serv Nefrol, Salamanca, Spain
Hernandez, D:
Hosp Reg Univ Malaga, Serv Nefrol, Malaga, Spain
Dominguez-Gil, B:
Org Nacl Trasplantes, Madrid, Spain
Pascual, J:
Hosp Mar, Serv Nefrol, Barcelona, Spain
gold
|